Increased isobutanol production in Saccharomyces cerevisiae by eliminating competing pathways and resolving cofactor imbalance
© Matsuda et al.; licensee BioMed Central Ltd. 2013
Received: 8 July 2013
Accepted: 5 November 2013
Published: 5 December 2013
Isobutanol is an important target for biorefinery research as a next-generation biofuel and a building block for commodity chemical production. Metabolically engineered microbial strains to produce isobutanol have been successfully developed by introducing the Ehrlich pathway into bacterial hosts. Isobutanol-producing baker’s yeast (Saccharomyces cerevisiae) strains have been developed following the strategy with respect to its advantageous characteristics for cost-effective isobutanol production. However, the isobutanol yields and titers attained by the developed strains need to be further improved through engineering of S. cerevisiae metabolism.
Two strategies including eliminating competing pathways and resolving the cofactor imbalance were applied to improve isobutanol production in S. cerevisiae. Isobutanol production levels were increased in strains lacking genes encoding members of the pyruvate dehydrogenase complex such as LPD1, indicating that the pyruvate supply for isobutanol biosynthesis is competing with acetyl-CoA biosynthesis in mitochondria. Isobutanol production was increased by overexpression of enzymes responsible for transhydrogenase-like shunts such as pyruvate carboxylase, malate dehydrogenase, and malic enzyme. The integration of a single gene deletion lpd1 Δ and the activation of the transhydrogenase-like shunt further increased isobutanol levels. In a batch fermentation test at the 50-mL scale from 100 g/L glucose using the two integrated strains, the isobutanol titer reached 1.62 ± 0.11 g/L and 1.61 ± 0.03 g/L at 24 h after the start of fermentation, which corresponds to the yield at 0.016 ± 0.001 g/g glucose consumed and 0.016 ± 0.0003 g/g glucose consumed, respectively.
These results demonstrate that downregulation of competing pathways and metabolic functions for resolving the cofactor imbalance are promising strategies to construct S. cerevisiae strains that effectively produce isobutanol.
KeywordsIsobutanol Ehrlich pathway Single-gene deletion Transhydrogenase-like shunt Saccharomyces cerevisiae
There is increasing interest in the production of branched higher alcohols from renewable biomass to be used as a next-generation biofuel and as a building block for commodity chemical production [1, 2]. Isobutanol is an important target for biorefinery research because of its preferable properties such as lower toxicity and higher octane values than its straight-chain counterpart . Metabolically engineered microbial strains to produce isobutanol have been developed by introducing the Ehrlich pathway into bacterial hosts, including Escherichia coli, Corynebacterium glutamicum, Clostridium cellulolyticum, Bacillus subtilis, and cyanobacteria [4–14]. In the recombinant strains, 2-ketoisovalerate, which is an intermediate in the valine biosynthetic pathway, is converted into isobutanol in a two-step reaction: decarboxylation of 2-ketoisovalerate to isobutylaldehyde by 2-keto acid decarboxylase (KDC), and subsequent reduction to isobutanol by alcohol dehydrogenase (ADH) [4, 15]. In bacterial hosts, isobutanol production near the theoretical maximal yield have been achieved by additional metabolic modifications such as deletion of competing pathways and resolving the cofactor imbalance caused by isobutanol production [7, 8, 13].
Baker’s yeast (Saccharomyces cerevisiae) has advantageous characteristics for cost-effective isobutanol production such as cell-recycling fermentation and tolerance against isobutanol and harsh conditions during fermentation . Isobutanol-producing S. cerevisiae strains have been developed following a bacterial strategy by construction of the Ehrlich pathway in the cytosol through expression of the kivd gene from Lactococcus lactis and ADH6 gene from S. cerevisiae. Isobutanol production was increased by the additional activation of the innate valine biosynthetic pathway in mitochondria and by the overexpression of Ilv2p, Ilv5p, and Ilv3p in the cytosol to construct the artificial pathway [18–20]. It was recently reported that the construction of the Ehrlich pathway in mitochondria is effective to increase isobutanol production because of the compartmentalization of the isobutanol biosynthetic pathway . However, the isobutanol yields and titers attained by the developed strains need to be further improved through engineering of S. cerevisiae metabolism. In this study, two strategies including eliminating competing pathways and resolving the cofactor imbalance were applied to improve isobutanol production in S. cerevisiae. Isobutanol production was increased by suppressing pyruvate dehydrogenase activity and by activating NADPH regeneration in the cytosol and mitochondria.
Disruption of genes related to pyruvate metabolism and valine biosynthesis
Yeast strains constructed in this study
MAT a ura3-52 lys2-801 ade2-101 trp1- Δ63 his3- Δ200 leu2- Δ1
MAT a his3 Δ1 leu2 Δ0 met15 Δ0 ura3 Δ0
Plasmids used in this study
Source or reference
Yeast expression vector containing PGK1 promoter, 2 μ origin, HIS3 marker, no expression (control plasmid)
Ishii et al., 2009 
Yeast expression vector containing PGK1 promoter, 2 μ origin, LEU2 marker, no expression (control plasmid)
Ishii et al., 2009 
Yeast expression vector containing PGK1 promoter, 2 μ origin, URA3 marker, no expression (control plasmid)
Ishii et al., 2009 
Yeast three gene expression vector containing ADH1, TDH3 and PGK1 promoters, 2 μ origin, HIS3 marker, no expression (control plasmid)
Ishii et al., in submission
Yeast three gene expression vector containing ADH1, TDH3, and PGK1 promoters, 2 μ origin, LEU2 marker, no expression (control plasmid)
Ishii et al., in submission
Yeast three gene expression vector containing ADH1, TDH3, and PGK1 promoters, 2 μ origin, URA3 marker, no expression (control plasmid)
Ishii et al., in submission
pGK423, expression of L. lactis 2-ketoisovalerate decarboxylase (kivd) gene
Kondo et al., 2012 
pGK425, expression of S. cerevisiae ILV2 gene
Kondo et al., 2012 
pGK426, expression of S. cerevisiae ADH6 gene
Kondo et al., 2012 
pATP425, co-expression of S. cerevisiae ILV5c, ILV3c, and ILV2c genes
2 μ origin, MET15 marker (pGK421-base), co-expression of S. cerevisiae ILV5c, ILV3c, and ILV2c genes
pATP423, expression of S. cerevisiae sMAE1 gene
pATP423, co-expression of S. cerevisiae sMAE1 and MDH2 genes
pATP423, co-expression of S. cerevisiae sMAE1, MDH2, and PYC2 genes
pATP423, expression of S. cerevisiae MAE1 gene
pATP423, co-expression of S. cerevisiae MAE1 and MDH2 genes
pATP423, co-expression of S. cerevisiae MAE1, MDH2, and PYC2 genes
pATP425, expression of S. cerevisiae ILV2 gene
pATP426, co-expression of L. lactis kivd and S. cerevisiae ADH6 genes
pATP426, co-expression of L. lactis kivd, S. cerevisiae ADH6, and ILV2 genes
The fermentation results indicated that the five single-gene deleted strains, including BSW100 irc15Δ, BSW100 pdc5Δ, BSW100 pdc6Δ, BSW100 mae1Δ, and BSW100 pyc2Δ and had no positive or negative effects on isobutanol production. Among the genes tested, the BSW100 thi3Δ strain showed slightly reduced production of isobutanol (Figure 2b). Although this finding suggests that 2-ketoisovalerate may be a substrate of the decarboxylation reaction catalyzed by Thi3p, further characterization of Thi3p is essential for more detailed functional annotation. In contrast, isobutanol production levels were slightly increased in BSW100 dld1Δ and BSW100 pyc1Δstrains. Furthermore, isobutanol production was remarkably increased to 138–159 mg/L in BSW100 pda1Δ, BSW100 pdb1Δ, BSW100 lpd1Δ, and BSW100 lat1Δ strains (Figure 2b). The cell growth of these mutants was essentially same levels with that of wild type (data not shown). In order to estimate effects of these mutations alone on the isobutanol production, BSW101, BSW101 pda1Δ, BSW101 pdb1Δ, BSW101 lpd1Δ, and BSW101 lat1Δ strains were constructed by introducing the blank vectors (Table 1). The fermentation test demonstrated that isobutanol production levels were increased to 68–77 mg/L at 72 h after the fermentation start for the mutant strains (data not shown). Because the PDA1, PDB1, LPD1, and LAT1 genes encode proteins in the pyruvate dehydrogenase complex, the results indicate that pyruvate supply for isobutanol biosynthesis is increased by reducing the activity of acetyl-CoA biosynthesis in the mitochondria.
Implementation of transhydrogenase-like shunt
The metabolic pathway shown in Figure 1 also indicates that isobutanol biosynthesis requires NADPH as a cofactor for the reaction catalyzed by Ilv5p and Adh6p. For synthesis of one molecule of isobutanol from two molecules of pyruvate, reducing power has to be supplied by two molecules of NADPH. Because ethanol synthesis from pyruvate essentially uses NADH as a cofactor, the activation of isobutanol biosynthesis should cause NADPH shortage and NADH abundance. This cofactor imbalance could be relieved by the activity of pyridine nucleotide transhydrogenase catalyzing the following reaction: NADH + NADP+ → NAD+ + NADPH [22, 23]. Although pyridine nucleotide transhydrogenase plays an important role in regulating the cellular redox state in many organisms, S. cerevisiae does not possess a gene encoding this enzyme . Furthermore, heterologous expression of a bacterial transhydrogenase was not successful in S. cerevisiae.
Recently, it has been demonstrated that the metabolic shunt involving anaplerotic reactions functions similar to transhydrogenase [3, 26, 27]. Through this shunt, pyruvate is sequentially converted to oxaloacetate, malate, and pyruvate by the activity of pyruvate carboxylase (PYC), malate dehydrogenase (MDH), and malic enzyme (MAE), as shown in Figure 1. The net stoichiometry of the shunt is as follows: ATP + NADH + NADP+ → ADP + Pi + NAD+ + NADPH, because the coenzyme preferences of MDH and MAE in S. cerevisiae are NADH and NADP+, respectively . The transhydrogenase-like shunt successfully resolved the cofactor imbalance in xylose-fermenting yeast expressing xylose reductase and xylulose dehydrogenase .
The transhydrogenase-like shuts were also introduced for the strain whose isobutanol biosynthetic pathway in the mitochondria was activated by the overexpression of Ilv2p (Figure 4a). The isobutanol production in the control strain BSW13 (23 ± 3 mg/L, YPH499/pATP426-kivd-ADH6/pATP425/pATP423) is lower than that of BSW4 (45 ± 4 mg/L, YPH499/pATP426-kivd-ADH6/pATP423). Since the leucine biosynthesis is branched from the valine biosynthesis and thus competing with the isobutanol biosynthesis, the leu2- Δ1 allele in BSW4 strain should have positive effect on isobutanol biosynthesis. On the other hands, the BMW13 strain showed a leucine-autotrophy by an additional introduction of ATP425 encoding LEU2 gene. The isobutanol level was increased to 117 ± 6 mg/L by the overexpression of Mdh2p, Pyc2p, and cytosolic sMae1p (BSW17 strain, Figure 4a), probably because of the simultaneous upregulation of 2-ketoisovalerate and NADPH supply in cytosol for isobutanol synthesis via the Ehrlich pathway. Furthermore, activation of the NADPH supply in the mitochondria by overexpression of mitochondrial Mae1p also increased the isobutanol titer to 139 ± 4 mg/L, as shown for the BSW18 strain. The isobutanol yields of BSW17 and BSW18 strains were 0.006 ± 0.0003 and 0.007 ± 0.0002 g/g glucose consumed, respectively, since glucose was completely consumed at 48 h after the fermentation start (Figure 4b). The fermentation profiles indicated that the glucose consumption rates and the ethanol production rate of BSW17 and BSW18 were essentially identical with that of BSW13 (Figure 4b). The isobutanol titer was decreased, however, by additional introduction of the MDH2 and PYC2 genes (BSW19 and BSW20 strains), which suggests that there is an optimal balance of enzyme activities among pyruvate carboxylase, malate dehydrogenase, and malic enzyme.
Construction of isobutanol overproducing strains
The isobutanol titer was increased by the additional introduction of transhydrogenase-like shunts as shown in BSW192 and BSW191 strains possessing pATP423-MAE1 and pATP423-PMsM plasmids, respectively. The isobutanol titer was increased to 94 ± 5 and 83 ± 2 mg/L by the activation of the NADPH supply in the cytosol and mitochondria, respectively. The cell growth was not affected by introducing pATP423-MAE1 and pATP423-PMsM plasmids (data not shown). The additional disruption of the LPD1 gene in the BSW192 and BSW191 strains further activated isobutanol biosynthesis. The isobutanol titer of the BSW205 and BSW206 strains reached 230 ± 13 and 221 ± 27 mg/L, respectively (Figure 5) that correspond to isobutanol yields at 0.012 ± 0.0007 and 0.011 ± 0.001 g/g glucose consumed, respectively. The glucose were completely consumed at 48 h after the fermentation start (data not shown).
In the metabolic engineering of microbial cell factories, elimination of competing pathways and resolution of the cofactor imbalance are essential to improve production of target compounds, as has been demonstrated in the construction of recombinant E. coli and C. glutamicum overproducing isobutanol [3, 4, 13]. In this study, these strategies were applied to increase isobutanol production in S. cerevisiae. The metabolic simulation of single gene-deletion strains demonstrated that suppression of ethanol biosynthesis by the deletion of alcohol dehydrogenase genes is effective to increase isobutanol yield . Although a recombinant S. cerevisiae strain lacking five alcohol dehydrogenase genes has recently been constructed , this strategy is unlikely to be effective because the Ehrlich pathway for isobutanol biosynthesis also requires an alcohol dehydrogenase gene (ADH6). Thus, to find other gene deletion targets, the isobutanol production of 12 single gene-deletion mutants expressing genes for isobutanol biosynthesis was experimentally investigated (Figure 2). A fermentation test showed that isobutanol production was significantly increased in strains lacking genes responsible for the pyruvate dehydrogenase (PDH) complex. In these strains, PDH activity was reduced but not eliminated by the deletion of a single protein of the complex, which resulted in increased carbon flux into isobutanol biosynthesis. These results highlight mechanisms regulating isobutanol biosynthesis in S. cerevisiae that could not be identified by computer simulation of metabolism based on metabolic flux balance analysis.
In the second part of this study, the cofactor imbalance in isobutanol-producing S. cerevisiae strains was resolved by introducing transhydrogenase-like shunts (Figure 4 and 5). The transhydrogenase-like shunt consisted of Pyc2p, Mdh2p, and Mae1p originally existing in S. cerevisiae (Figure 1) [26, 31]. However, the shunt was hardly functional in S. cerevisiae because the deletion of these genes showed no negative effect on isobutanol production (Figure 2). The recombinant strains overexpressing Mae1p showed improved production of isobutanol (Figure 4a), which indicates that increased NADPH and pyruvate supply in mitochondria through the activation of mitochondrial malic enzyme (Mae1p) could be a driving force to increase isobutanol biosynthesis. It was also demonstrated that isobutanol production in S. cerevisae was increased by the expression of malic enzyme in the cytosol (sMae1p) to supply NADPH in the cytosol (Figure 4a). The effect of the transhydrogenase-like function on NADH/NAD+ and NADPH/NADP+ levels was confirmed in xylose-fermenting S. cerevisae overexpressing the shunt . The improvement of isobutanol production in S. cerevisiae by resolving the cofactor imbalance was demonstrated for the first time in this study.
The integration of PDH suppression by lpd1 Δ and activation of the transhydrogenase-like shunt in BSW205 and BSW206 strains successfully increased the isobutanol levels to 230 ± 13 and 221 ± 27 mg/L, respectively (Figure 5). In the batch fermentation test at the 50-mL scale from 100 g/L glucose using these recombinant strains, the isobutanol titer reached 1.62 ± 0.11 and 1.61 ± 0.03 g/L at 24 h after the start of fermentation (Figure 6). The titer corresponds to the yield at 0.016 ± 0.001 and 0.016 ± 0.0003 g/g glucose consumed, respectively.
All recombinant strains constructed in this study chiefly produced ethanol. For instance, the ethanol yield from glucose of BSW205 and BSW206 strains in the batch fermentation test at the 50-mL scale was 0.42 ± 0.01 and 0.42 ± 0.003 g/g glucose consumed, respectively (Figure 6), which indicates that restriction of ethanol biosynthesis from pyruvate is unavoidable to drastically improve isobutanol yield. However, it has been demonstrated that downregulation of ethanol biosynthesis by deleting the pyruvate decarboxylase and alcohol dehydrogenase genes seriously hampers active cell growth [30, 32]. In this regard, identification of the MTH1ΔT allele is a promising because the mutation enables S. cerevisiae strains lacking three pyruvate dehydrogenase genes to actively grow with reduced ethanol production . Recombinant S. cerevisiae strains effectively producing isobutanol will be constructed by integrating further activation of pathways for isobutanol biosynthesis [19–21], the down-regulation of competing pathways for acetyl-CoA and ethanol synthesis, and metabolic functions for resolving the cofactor imbalance as demonstrated in this study.
Strains, plasmids, and yeast transformation
Primers used in this study
The transformants were cultured for 72 h at 30°C in 5 mL of SD minimal medium (6.7 g/L yeast nitrogen base without amino acids and 20 g/L glucose) containing the required amino acids. Following centrifugation at 3,000 rpm for 5 min and removal of supernatant, the yeast cells were cultured in 5 mL of fresh SD minimal medium containing the required amino acids. The concentrations of isobutanol and ethanol in the medium at 48 and 72 h after the start of fermentation were determined using GC-MS (GCMS-QP2010 Plus; Shimadzu) following a previously described procedure . The glucose concentrations were determined by Glucose C-II Test Wako Kit (Wako Pure Chemicals, Tokyo, Japan).
For flask-scale fermentation, the yeast transformants were aerobically cultivated in SD minimal medium containing the required amino acids for 48 h at 30°C. The cells were collected by centrifugation at 1,000 × g for 5 min at 4°C and washed twice with sterile water. The cells were then inoculated into 50 mL of YP medium (containing 10 g/L yeast extract and 20 g/L peptone) with 100 g/L glucose. The initial cell concentration was adjusted to 30 g of wet cells per liter (corresponding to OD 20 and 6.7 g of dry cells per liter). All fermentations were performed at 30°C with mild agitation in 100-mL closed bottles equipped with a bubbling CO2 outlet.
This work was financed by the Industrial Technology Research Grant Program for 2011 of the New Energy and Industrial Technology Development Organization (NEDO) of Japan and Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe), MEXT, Japan. This work is also supported in part by Grants in Aid for Scientific Research (B) No 25820400.
- Weber C, Farwick A, Benisch F, Brat D, Dietz H, Subtil T, Boles E: Trends and challenges in the microbial production of lignocellulosic bioalcohol fuels. Appl Microbiol Biotechnol. 2010, 87 (4): 1303-1315. 10.1007/s00253-010-2707-z.View ArticleGoogle Scholar
- Connor MR, Liao JC: Microbial production of advanced transportation fuels in non-natural hosts. Curr Opin Biotechnol. 2009, 20 (3): 307-315. 10.1016/j.copbio.2009.04.002.View ArticleGoogle Scholar
- Blombach B, Eikmanns BJ: Current knowledge on isobutanol production with Escherichia coli, Bacillus subtilis and Corynebacterium glutamicum. Bioeng Bugs. 2011, 2 (6): 346-350. 10.4161/bbug.2.6.17845.View ArticleGoogle Scholar
- Atsumi S, Hanai T, Liao JC: Non-fermentative pathways for synthesis of branched-chain higher alcohols as biofuels. Nature. 2008, 451 (7174): 86-89. 10.1038/nature06450.View ArticleGoogle Scholar
- Atsumi S, Higashide W, Liao JC: Direct photosynthetic recycling of carbon dioxide to isobutyraldehyde. Nat Biotechnol. 2009, 27 (12): 1177-1180. 10.1038/nbt.1586.View ArticleGoogle Scholar
- Atsumi S, Li Z, Liao JC: Acetolactate synthase from Bacillus subtilis serves as a 2-ketoisovalerate decarboxylase for isobutanol biosynthesis in Escherichia coli. Appl Environ Microbiol. 2009, 75 (19): 6306-6311. 10.1128/AEM.01160-09.View ArticleGoogle Scholar
- Atsumi S, Wu TY, Eckl EM, Hawkins SD, Buelter T, Liao JC: Engineering the isobutanol biosynthetic pathway in Escherichia coli by comparison of three aldehyde reductase/alcohol dehydrogenase genes. Appl Microbiol Biotechnol. 2010, 85 (3): 651-657. 10.1007/s00253-009-2085-6.View ArticleGoogle Scholar
- Baez A, Cho KM, Liao JC: High-flux isobutanol production using engineered Escherichia coli: a bioreactor study with in situ product removal. Appl Microbiol Biotechnol. 2011, 90 (5): 1681-1690. 10.1007/s00253-011-3173-y.View ArticleGoogle Scholar
- Bastian S, Liu X, Meyerowitz JT, Snow CD, Chen MM, Arnold FH: Engineered ketol-acid reductoisomerase and alcohol dehydrogenase enable anaerobic 2-methylpropan-1-ol production at theoretical yield in Escherichia coli. Metab Eng. 2011, 13 (3): 345-352. 10.1016/j.ymben.2011.02.004.View ArticleGoogle Scholar
- Blombach B, Riester T, Wieschalka S, Ziert C, Youn JW, Wendisch VF, Eikmanns BJ: Corynebacterium glutamicum tailored for efficient isobutanol production. Appl Environ Microbiol. 2011, 77 (10): 3300-3310. 10.1128/AEM.02972-10.View ArticleGoogle Scholar
- Higashide W, Li Y, Yang Y, Liao JC: Metabolic engineering of Clostridium cellulolyticum for production of isobutanol from cellulose. Appl Environ Microbiol. 2011, 77 (8): 2727-2733. 10.1128/AEM.02454-10.View ArticleGoogle Scholar
- Smith KM, Cho KM, Liao JC: Engineering Corynebacterium glutamicum for isobutanol production. Appl Microbiol Biotechnol. 2010, 87 (3): 1045-1055. 10.1007/s00253-010-2522-6.View ArticleGoogle Scholar
- Yamamoto S, Suda M, Niimi S, Inui M, Yukawa H: Strain optimization for efficient isobutanol production using Corynebacterium glutamicum under oxygen deprivation. Biotechnol Bioeng. 2013, 110 (10): 2938-2948.View ArticleGoogle Scholar
- Li S, Wen J, Jia X: Engineering Bacillus subtilis for isobutanol production by heterologous Ehrlich pathway construction and the biosynthetic 2-ketoisovalerate precursor pathway overexpression. Appl Microbiol Biotechnol. 2011, 91 (3): 577-589. 10.1007/s00253-011-3280-9.View ArticleGoogle Scholar
- Hazelwood LA, Daran JM, van Maris AJ, Pronk JT, Dickinson JR: The Ehrlich pathway for fusel alcohol production: a century of research on Saccharomyces cerevisiae metabolism. Appl Environ Microbiol. 2008, 74 (8): 2259-2266. 10.1128/AEM.02625-07.View ArticleGoogle Scholar
- Kondo A, Ishii J, Hara KY, Hasunuma T, Matsuda F: Development of microbial cell factories for bio-refinery through synthetic bioengineering. J Biotechnol. 2013, 163 (2): 204-216. 10.1016/j.jbiotec.2012.05.021.View ArticleGoogle Scholar
- Kondo T, Tezuka H, Ishii J, Matsuda F, Ogino C, Kondo A: Genetic engineering to enhance the Ehrlich pathway and alter carbon flux for increased isobutanol production from glucose by Saccharomyces cerevisiae. Journal of Biotechnology. 2012, 159 (1–2): 32-37.View ArticleGoogle Scholar
- Chen X, Nielsen KF, Borodina I, Kielland-Brandt MC, Karhumaa K: Increased isobutanol production in Saccharomyces cerevisiae by overexpression of genes in valine metabolism. Biotechnol Biofuels. 2011, 4: 21-10.1186/1754-6834-4-21.View ArticleGoogle Scholar
- Brat D, Weber C, Lorenzen W, Bode HB, Boles E: Cytosolic re-localization and optimization of valine synthesis and catabolism enables inseased isobutanol production with the yeast Saccharomyces cerevisiae. Biotechnol Biofuels. 2012, 5 (1): 65-10.1186/1754-6834-5-65.View ArticleGoogle Scholar
- Matsuda F, Kondo T, Ida K, Tezuka H, Ishii J, Kondo A: Construction of an artificial pathway for isobutanol biosynthesis in the cytosol of Saccharomyces cerevisiae. Biosci Biotechnol Biochem. 2012, 76 (11): 2139-2141. 10.1271/bbb.120420.View ArticleGoogle Scholar
- Avalos JL, Fink GR, Stephanopoulos G: Compartmentalization of metabolic pathways in yeast mitochondria improves the production of branched-chain alcohols. Nat Biotechnol. 2013, 31: 335-341. 10.1038/nbt.2509.View ArticleGoogle Scholar
- Arkblad EL, Betsholtz C, Rydstrom J: The cDNA sequence of proton-pumping nicotinamide nucleotide transhydrogenase from man and mouse. Biochim Biophys Acta. 1996, 1273 (3): 203-205. 10.1016/0005-2728(95)00159-X.View ArticleGoogle Scholar
- Sauer U, Canonaco F, Heri S, Perrenoud A, Fischer E: The soluble and membrane-bound transhydrogenases UdhA and PntAB have divergent functions in NADPH metabolism of Escherichia coli. J Biol Chem. 2004, 279 (8): 6613-6619.View ArticleGoogle Scholar
- Anderlund M, Nissen TL, Nielsen J, Villadsen J, Rydstrom J, Hahn-Hagerdal B, Kielland-Brandt MC: Expression of the Escherichia coli pntA and pntB genes, encoding nicotinamide nucleotide transhydrogenase, in Saccharomyces cerevisiae and its effect on product formation during anaerobic glucose fermentation. Appl Environ Microbiol. 1999, 65 (6): 2333-2340.Google Scholar
- Nissen TL, Anderlund M, Nielsen J, Villadsen J, Kielland-Brandt MC: Expression of a cytoplasmic transhydrogenase in Saccharomyces cerevisiae results in formation of 2-oxoglutarate due to depletion of the NADPH pool. Yeast. 2001, 18 (1): 19-32. 10.1002/1097-0061(200101)18:1<19::AID-YEA650>3.0.CO;2-5.View ArticleGoogle Scholar
- Moreira dos Santos M, Raghevendran V, Kotter P, Olsson L, Nielsen J: Manipulation of malic enzyme in Saccharomyces cerevisiae for increasing NADPH production capacity aerobically in different cellular compartments. Metab Eng. 2004, 6 (4): 352-363. 10.1016/j.ymben.2004.06.002.View ArticleGoogle Scholar
- Suga H, Matsuda F, Hasunuma T, Ishii J, Kondo A: Implementation of a transhydrogenase-like shunt to counter redox imbalance during xylose fermentation in Saccharomyces cerevisiae. Appl Microbiol Biotechnol. 2012, 97 (4): 1669-1678.View ArticleGoogle Scholar
- Matsuda F, Furusawa C, Kondo T, Ishii J, Shimizu H, Kondo A: Engineering strategy of yeast metabolism for higher alcohol production. Microb Cell Fact. 2011, 10 (1): 70-10.1186/1475-2859-10-70.View ArticleGoogle Scholar
- Boles E, de Jong-Gubbels P, Pronk JT: Identification and characterization of MAE1, the Saccharomyces cerevisiae structural gene encoding mitochondrial malic enzyme. J Bacteriol. 1998, 180 (11): 2875-2882.Google Scholar
- Ida Y, Furusawa C, Hirasawa T, Shimizu H: Stable disruption of ethanol production by deletion of the genes encoding alcohol dehydrogenase isozymes in Saccharomyces cerevisiae. J Biosci Bioeng. 2012, 113 (2): 192-195. 10.1016/j.jbiosc.2011.09.019.View ArticleGoogle Scholar
- Herrgard MJ, Swainston N, Dobson P, Dunn WB, Arga KY, Arvas M, Bluthgen N, Borger S, Costenoble R, Heinemann M, et al: A consensus yeast metabolic network reconstruction obtained from a community approach to systems biology. Nat Biotechnol. 2008, 26 (10): 1155-1160. 10.1038/nbt1492.View ArticleGoogle Scholar
- Hohmann S: Characterization of PDC6, a third structural gene for pyruvate decarboxylase in Saccharomyces cerevisiae. J Bacteriol. 1991, 173 (24): 7963-7969.Google Scholar
- Oud B, Flores CL, Gancedo C, Zhang X, Trueheart J, Daran JM, Pronk JT, van Maris AJ: An internal deletion in MTH1 enables growth on glucose of pyruvate-decarboxylase negative, non-fermentative Saccharomyces cerevisiae. Microb Cell Fact. 2012, 11: 131-10.1186/1475-2859-11-131.View ArticleGoogle Scholar
- Ishii J, Izawa K, Matsumura S, Wakamura K, Tanino T, Tanaka T, Ogino C, Fukuda H, Kondo A: A simple and immediate method for simultaneously evaluating expression level and plasmid maintenance in yeast. J Biochem. 2009, 145 (6): 701-708. 10.1093/jb/mvp028.View ArticleGoogle Scholar
- Ito H, Fukuda Y, Murata K, Kimura A: Transformation of intact yeast cells treated with alkali cations. J Bacteriol. 1983, 153 (1): 163-168.Google Scholar
- Katahira S, Mizuike A, Fukuda H, Kondo A: Ethanol fermentation from lignocellulosic hydrolysate by a recombinant xylose- and cellooligosaccharide-assimilating yeast strain. Appl Microbiol Biotechnol. 2006, 72 (6): 1136-1143. 10.1007/s00253-006-0402-x.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.